GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (FRA:0IL) » Definitions » Short Percentage of Float

Intelgenx Technologies (FRA:0IL) Short Percentage of Float


View and export this data going back to 2016. Start your Free Trial

What is Intelgenx Technologies Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Intelgenx Technologies's Short Percentage of Float

For the Biotechnology subindustry, Intelgenx Technologies's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intelgenx Technologies's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intelgenx Technologies's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Intelgenx Technologies's Short Percentage of Float falls into.


Intelgenx Technologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (FRA:0IL) » Definitions » Short Percentage of Float
Comparable Companies
PLUR ABIO RNXT VTVT AURX LUMO VINC EQ ELEV OCEA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XKRX:068270 BNTX ALNY
Traded in Other Exchanges
IGXT:USA IGX:Canada
Address
6420 Abrams, Ville Saint Laurent, QC, CAN, H4S 1Y2
Website
https://www.intelgenx.com
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.

Intelgenx Technologies Headlines

No Headlines